Profile data is unavailable for this security.
About the company
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
- Revenue in USD (TTM)23.75m
- Net income in USD-22.08m
- Incorporated1990
- Employees122.00
- LocationStereotaxis Inc710 N Tucker Blvd, Ste 110ST. LOUIS 63101United StatesUSA
- Phone+1 (314) 678-6100
- Fax+1 (314) 678-6159
- Websitehttps://www.stereotaxis.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EUDA Health Holdings Ltd | 3.71m | -8.44m | 132.78m | 106.00 | -- | -- | -- | 35.82 | -0.3685 | -0.4384 | 0.1707 | -0.3045 | 0.2752 | -- | 3.55 | 34,966.61 | -62.62 | -- | -- | -- | 22.72 | -- | -227.57 | -- | -- | -1.49 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
InfuSystem Holdings Inc | 129.37m | 366.00k | 144.31m | 499.00 | 432.31 | 2.70 | 11.52 | 1.12 | 0.0157 | 0.0157 | 5.99 | 2.51 | 1.22 | 10.38 | 6.44 | 259,264.50 | 0.3465 | 4.60 | 0.401 | 5.69 | 49.68 | 56.43 | 0.2829 | 4.07 | 1.64 | 1.97 | 0.3898 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
Akoya Biosciences Inc | 93.22m | -60.35m | 149.98m | 330.00 | -- | 6.74 | -- | 1.61 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
Acme United Corp | 192.71m | 19.45m | 155.82m | 645.00 | 8.48 | 1.50 | 6.23 | 0.8086 | 4.97 | 4.97 | 48.59 | 28.13 | 1.15 | 2.07 | 4.83 | 298,770.50 | 11.60 | 7.09 | 13.79 | 8.29 | 39.40 | 35.72 | 10.09 | 5.50 | 1.77 | 6.60 | 0.2621 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
Stereotaxis Inc | 23.75m | -22.08m | 163.39m | 122.00 | -- | 14.10 | -- | 6.88 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
CVRx Inc | 44.39m | -54.39m | 166.23m | 200.00 | -- | 3.00 | -- | 3.74 | -2.57 | -2.57 | 2.10 | 2.54 | 0.4209 | 0.6253 | 5.79 | 221,965.00 | -51.56 | -- | -56.39 | -- | 84.40 | -- | -122.52 | -- | 8.85 | -18.48 | 0.3467 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
Nevro Corp | 426.10m | -77.44m | 175.23m | 1.22k | -- | 0.6376 | -- | 0.4113 | -2.12 | -2.12 | 11.69 | 7.37 | 0.7266 | 1.11 | 5.93 | 350,697.90 | -13.21 | -13.64 | -15.59 | -16.68 | 68.06 | 68.54 | -18.18 | -20.67 | 3.53 | -28.95 | 0.4433 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
Accuray Inc | 446.55m | -15.55m | 176.48m | 987.00 | -- | 3.91 | -- | 0.3952 | -0.1591 | -0.1591 | 4.54 | 0.45 | 0.9423 | 2.14 | 5.36 | 452,432.60 | -3.28 | -1.37 | -5.61 | -2.33 | 32.05 | 36.43 | -3.48 | -1.55 | 0.947 | 0.2623 | 0.7925 | -- | -0.2355 | 1.29 | -67.51 | -- | -3.54 | -- |
Neuropace Inc | 71.82m | -29.90m | 178.39m | 171.00 | -- | 18.01 | -- | 2.48 | -1.09 | -1.09 | 2.61 | 0.3392 | 0.7305 | 1.74 | 6.49 | 419,994.20 | -30.41 | -- | -34.66 | -- | 74.15 | -- | -41.63 | -- | 5.47 | -4.37 | 0.8565 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
Senseonics Holdings Inc | 24.04m | -80.46m | 181.61m | 132.00 | -- | 314.04 | -- | 7.55 | -0.1323 | -0.1323 | 0.0395 | 0.0714 | 0.1815 | 2.58 | 5.99 | 182,113.60 | -60.74 | -73.65 | -74.52 | -106.97 | 12.04 | -40.41 | -334.69 | -649.86 | 2.89 | -10.93 | 0.5802 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
Electromed Inc | 54.72m | 5.15m | 184.23m | 174.00 | 37.85 | 4.25 | 30.75 | 3.37 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
Semler Scientific Inc | 61.74m | 15.82m | 184.88m | 92.00 | 13.01 | 2.36 | 11.21 | 2.99 | 2.03 | 2.03 | 7.93 | 11.22 | 0.7706 | 16.26 | 9.15 | 671,097.80 | 19.74 | 38.83 | 22.00 | 44.41 | 88.67 | 90.22 | 25.62 | 32.58 | 3.66 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
Orchestra Biomed Holdings Inc | 2.08m | -55.58m | 189.12m | 56.00 | -- | 4.06 | -- | 90.97 | -1.57 | -1.57 | 0.0586 | 1.23 | 0.021 | 1.34 | 16.57 | 37,125.00 | -56.06 | -- | -64.66 | -- | 92.02 | -- | -2,673.26 | -- | 4.58 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
LifeMD Inc | 178.28m | -26.60m | 191.66m | 207.00 | -- | -- | -- | 1.08 | -0.7004 | -0.7004 | 4.70 | -0.101 | 3.59 | 6.86 | 38.19 | 861,255.40 | -44.31 | -153.05 | -333.96 | -526.91 | 88.92 | 83.66 | -12.34 | -45.44 | 0.8327 | -8.19 | 1.13 | -- | 28.15 | 78.90 | 51.27 | -- | 143.64 | -- |
Trubridge Inc | 336.56m | -52.28m | 194.48m | 3.22k | -- | 1.07 | -- | 0.5779 | -3.68 | -3.68 | 23.64 | 12.12 | 0.7947 | 196.76 | 5.88 | 104,553.30 | -12.66 | 1.25 | -14.34 | 1.41 | 48.70 | 50.40 | -15.93 | 1.56 | 1.76 | 0.6115 | 0.4985 | 45.06 | 3.91 | 3.89 | -387.73 | -- | 88.71 | -- |
Holder | Shares | % Held |
---|---|---|
DAFNA Capital Management LLCas of 01 Jul 2024 | 13.68m | 16.55% |
Lagoda Investment Management LPas of 31 Mar 2024 | 3.83m | 4.63% |
Redmile Group LLCas of 31 Mar 2024 | 3.31m | 4.00% |
Arbiter Partners Capital Management LLCas of 14 Jun 2024 | 2.77m | 3.35% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 2.60m | 3.14% |
Archon Capital Management LLCas of 31 Mar 2024 | 2.50m | 3.03% |
Geode Capital Management LLCas of 30 Jun 2024 | 1.30m | 1.57% |
Essex Investment Management Co. LLCas of 31 Mar 2024 | 1.19m | 1.45% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 1.06m | 1.28% |
Prescott Group Capital Management LLCas of 30 Jun 2024 | 823.65k | 1.00% |